News
Press Releases
-
January 6, 2021
Genesis Drug Discovery and Development expands its presence in the clinical space by acquiring STATKING Clinical Services
View -
December 9, 2020
Genesis Biotechnology Group announces second year of CRO relationship with Yale University
View -
August 5, 2020
Genesis Biotechnology Group acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its portfolio of Preclinical Services
View -
August 4, 2020
Genesis Drug Discovery & Development (GD3) Announces Appointment of Anthony Rohr, as Chief Executive Officer of PharmOptima.
View -
November 19, 2019
Genesis Biotechnology Group acquires NEDP to grow the Preclinical Chemistry services portfolio of Genesis Drug Discovery & Development
View -
June 18, 2019
Genesis Drug Discovery & Development Expands Preclinical Contract Research Portfolio by Acquiring NexusPharma.
View -
January 1, 2016
EPO Berlin-Buch GmbH announces strategic partnership for the American market: EPO starts strategic collaboration with NexusPharma to foster its market position in the USA
View